Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 4 Relationship between tumor response, concurrent chemotherapy and patterns of treatment failure (n = 83)

From: Three-dimensional conformal radiotherapy with concurrent chemotherapy for postoperative recurrence of esophageal squamous cell carcinoma: clinical efficacy and failure pattern

Characteristic Persistent local disease (%) Locoregional recurrence (%) Distant metastasis (%) Multiple failures (%)
Tumor response     
CR (n = 37) 0 (0%) 6 (16.2%) 5 (13.5%) 1 (2.7%)
Non-CR (n = 46) 9 (19.6%) 12 (26.1%) 13 (28.3%) 1 (2.2%)
Concurrent chemotherapy     
PF (n = 39) 6 (15.4%) 12 (30.8%) 9 (23.1%) 1 (2.6%)
TP (n = 44) 3 (6.8%) 6 (13.6%) 9 (20.5%) 1 (2.3%)
Total (n = 83) 9 (10.8%) 18 (21.7%) 18 (21.7%) 2 (2.4%)